More news on the homepage
Dr. med. Katja Dinkelborg, PhD has been awarded the HBRS PhD Prize for the year 2025. The award is presented annually by the Hannover Biomedical Research School (HBRS) to outstanding young scientists who have completed their doctorate at the HBRS with excellent results. The prize, endowed with 1,000 euros, was awarded during the opening ceremony of the new HBRS academic year on October 6, 2025.
Dr. Dinkelborg, PhD received her doctorate in June 2025 with the grade summa cum laude as part of the HBRS "Molecular Medicine" program. Part of her work was published earlier this year in the prestigious journal Nature Communications . Over the past four years, she has been conducting research in Dr. Patrick Behrendt's working group at Twincore in the Institute of Experimental Virology under the direction of Prof. Dr. Thomas Pietschmann. Among other things, she was supported by a Clinical Leave Scholarship from the DZIF. Dr. Dinkelborg also works as a physician in the Clinical Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology.
Her research work in collaboration with Prof. Thomas Krey from the University of Lübeck focused on the identification of human monoclonal antibodies to neutralize the hepatitis E virus. The team has already filed a patent application and aims to establish the first preventive and therapeutic option against hepatitis E virus infections - a promising innovation against the most common cause of acute viral hepatitis.
To the publication: Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice | Nature Communications